Cardiovascular Ultrasound Industry Overview The global cardiovascular ultrasound market size is expected to reach USD 2.33 billion by 2028, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.7% over the forecast period. Rising investment in the Medtech industry, increasing R&D activities, and high prevalence of cardiovascular diseases are the key factors driving market growth. Benefits associated with cardiovascular ultrasound over conventional methods include quick recovery, reduced span of hospitalization, and fewer post-operative complications. These benefits along with the rising geriatric population are expected to propel the demand for cardiovascular ultrasound diagnosis over the forecast period. Cardiovascular Ultrasound Market Segmentation Grand View Research has segmented the global cardiovascular ultrasound market report on the basis of type, technology, display, end-use, and region: Based on the Type Insights, the market is segmented into Transthoracic Echocardiography, Transesophageal Echocardiography, Fetal Echocardiography, Others.
Based on the Technology Insights, the market is segmented into 2D, 3D/4D, Doppler.
Based on the Display Insights, the market is segmented into B/W, Color.
Based on the End-use Insights, the market is segmented into Hospital, Diagnostic Centers, Ambulatory Care Centers, Others.
Cardiovascular Ultrasound Regional Outlook
Key Companies Profile & Market Share Insights Key market players are undertaking various business strategies, such as forming strategic alliances, to expand their geographical reach and enhance product portfolios of CVUS systems. For instance, in October 2020, Royal Philips launched Ultrasound 3300 in India. Some prominent players in the global cardiovascular ultrasound market include
Order a free sample PDF of the Cardiovascular Ultrasound Market Intelligence Study, published by Grand View Research.
0 Comments
Antisense & RNAi Therapeutics Industry Overview The global antisense & RNAi therapeutics market size is expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Development in biological vectors and nanotechnology and rising external funding to conduct clinical studies pertaining to introduction of novel drug moieties play a vital role in the process of product development and fuel growth in this market. Antisense & RNAi Therapeutics Market Segmentation Grand View Research has segmented the global antisense & RNAi therapeutics market on the basis of technology, application, route of administration, and region: Based on the Technology Insights, the market is segmented into RNA Interference, Antisense RNA.
Based on the Route of Administration Insights, the market is segmented into Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods.
Based on the Application Insights, the market is segmented into Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Renal Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, Other.
Antisense & RNAi Therapeutics Regional Outlook
Key Companies Profile & Market Share Insights The companies are involved in the development of RNAi therapies and platforms that offer medicines, diagnostics, and personalized treatment options for key diseases. Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Akcea Therapeutics, Quark Pharmaceuticals, and Gene Signal are several other companies with stronger pipeline portfolio. Some prominent players in the global antisense & RNAi therapeutics market include
Order a free sample PDF of the Antisense & RNAi Therapeutics Market Intelligence Study, published by Grand View Research. Scaffold Technology Industry Overview The global scaffold technology market size is expected to reach USD 2.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2021 to 2028. The market growth can be primarily attributed to the growing popularity of bioprinting for mimicking the tissue microenvironment in printed 3D tissue models. The need to expand the horizon of multidisciplinary research areas has supplemented the adoption of scaffold technologies in 3D printed models. Scaffold Technology Market Segmentation Grand View Research has segmented the global scaffold technology market based on type, application, disease type, end-use, and region: Based on the Type Insights, the market is segmented into Hydrogels, Wound Healing, 3D Bioprinting, Immunomodulation.
Based on the Application Insights, the market is segmented into Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery, Others.
Based on the Disease Type Insights, the market is segmented into Orthopedics, Musculoskeletal, & Spine, Cancer, Skin & Integumentary, Dental, Cardiology & Vascular, Neurology, Urology, GI, Gynecology, Others.
Based on the End-use Insights, the market is segmented into Biotechnology and Pharmaceutical Industries, Research Laboratories and Institutes, Hospitals and Diagnostic Centers, Others.
Scaffold Technology Regional Outlook
Key Companies Profile & Market Share Insights The rising initiatives for promoting products based on scaffold technology are contributing to the growth of the market for scaffold technology. For instance, in January 2021, UnitedHealthcare expanded its medical policies for Vericel Corporation’s MACI (autologous cultured chondrocytes on porcine collagen membrane) for including coverage for individuals with multiple cartilage defects in the knee and cartilage defects in the patella. Some prominent players in the global scaffold technology market include
Order a free sample PDF of the Scaffold Technology Market Intelligence Study, published by Grand View Research. The global glycomics/glycobiology market size is expected to reach USD 2.4 billion by 2026 registering a CAGR of 14.7%, according to a new report by Grand View Research, Inc. Rising focus on glycomics and proteomics research has led to the growth of this market. Significant investments in this field have also enabled academic researchers to develop new tools. Thus, the field of glycoscience is growing, which is a high impact rendering driver for the market. Glycans are essential in biological processes and research on them helps in understanding the biology more comprehensively, without specializing in glycobiology. According to 2018 BDO Biotech Briefing, the average R&D expenditure of the mid-sized biotech companies increased around 14% from 2016 to 2017. Glycomics Market Segmentation Grand View Research has segmented the global glycomics/glycobiology market on the basis of product, application, end use, and region: Based on the Product Insights, the market is segmented into Enzymes, Kits, Reagents, Instruments.
Based on the Application Insights, the market is segmented into Drug Discovery & Development, Diagnostics, Others.
Based on the End Use Insights, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, CROs.
Glycomics Regional Outlook
Key Companies Profile & Market Share Insights New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth. For instance, in February 2018, Merck KGaA invested 40 million Euros to enhance their distribution and manufacturing services in the Asian region. Some prominent players in the global glycomics market include
Order a free sample PDF of the Glycomics Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Hematology Diagnostics Market To Grow As Of Increasing Prevalence Of Blood Disorders To 20258/23/2022 Hematology Diagnostics Industry Overview The global hematology diagnostics market size is expected to reach USD 9.39 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 5.85% over the forecast period. Increasing prevalence of blood disorders coupled with adoption of automated testing processes are projected to propel the market growth. Automation of hematology diagnostics process have led to reduced turnaround time thereby accelerating the overall treatment regimen. Furthermore, automation has also led to reduced administrative errors and overall costs of diagnostic tests. Thus, it is expected to boost growth of the hematology testing market in the forthcoming years. The advent of Point-Of-Care (PoC) hematology testing devices has led to improved diagnostic and patient outcomes. These devices are user-friendly and are available for use outside the hospital settings. This is anticipated to increase the acceptability and accessibility of hematology testing which, in turn, is anticipated to propel market growth. Hematology Diagnostics Market Segmentation Grand View Research has segmented the global hematology diagnostics market based on product, end-use, test type, and region: Based on the Product Insights, the market is segmented into Instrument, Consumables.
Based on the End-use Insights, the market is segmented into Hospitals, Diagnostic labs, Others.
Based on the Test Type Insights, the market is segmented into Blood count, Platelet function, Hemoglobin, Hematocrit.
Hematology Diagnostics Regional Outlook
Key Companies Profile & Market Share Insights New product developments, mergers and acquisitions, and collaborations are some of the major strategies adopted by these players to counter the stiff competition. Some prominent players in the global hematology diagnostics market include
Order a free sample PDF of the Hematology Diagnostics Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: https://www.grandviewresearch.com Follow Us: LinkedIn | Twitter Pharmaceutical Filtration Industry Overview The global pharmaceutical filtration market size is expected to reach USD 37.3 billion by the year 2025 growing at a CAGR of 12.1%, according to a new report by Grand View Research, Inc. The growing expansion of the biopharmaceutical industry have resulted in enormous growth of the market with new and more enhanced technologies being used to cater to the need of drug manufacturers. Increasing demand for therapeutic biopharmaceuticals such as antibodies, hormones, and vaccines is a major factor that drives growth of the market during forecast period. Thus, many pharmaceuticals and biotechnology companies have begun to focus on the development of advanced biologics for the treatment of severe chronic diseases including cancer, heart disease, and rheumatic arthritis. Pharmaceutical Filtration Market Segmentation Grand View Research has segmented the global pharmaceutical filtration market on the basis of product, technique, application, scale of operation, and region: Based on the Product Insights, the market is segmented into membrane filters, prefilters & depth media, single-use systems, cartridges & capsules, filter holders, filtration accessories, others.
Based on the Technique Insights, the market is segmented into Microfiltration, Ultrafiltration, Cross flow filtration, Nanofiltration, Others.
Based on the Application Insights, the market is segmented into Final product processing, Raw material filtration, Cell separation, Water purification, Air purification.
Based on the Scale of Operation Insights, the market is segmented into Manufacturing scale, Pilot scale, Research & development scale.
Pharmaceutical Filtration Regional Outlook
Key Companies Profile & Market Share Insights The dominant players provide an extensive product range and are constantly engaged in the expansion of their existing portfolios. The majority of these players have an intensified distribution network across a wide geographical region. Some prominent players in the global pharmaceutical filtration market include:
Order a free sample PDF of the Pharmaceutical Filtration Market Intelligence Study, published by Grand View Research. Biobanks Industry Overview The global biobanks market size is expected to reach USD 100.8 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 4.6% during the forecast period. Biobanks continue to evolve with the introduction of new technologies, such as NGS, and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market. The quality of biospecimens can significantly influence disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples. U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples. This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space. Biobanks Market Segmentation Grand View Research has segmented the global biobanks market on the basis of product, service, biospecimen type, biobanks type, application, and region: Based on the Product Insights, the market is segmented into Biobanking Equipment, Biobanking Consumables, Laboratory Information Management Systems.
Based on the Service Insights, the market is segmented into biobanking & repository, lab processing, qualification/validation, cold chain logistics, other services.
Based on the Biospecimen Type Insights, the market is segmented into Human Tissues, Human Organs, Stem Cells, Other Biospecimens.
Based on the Type Insights, the market is segmented into Physical/Real Biobank, Virtual Biobanks.
Based on the Application Insights, the market is segmented into Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Other Applications.
Biobanks Regional Outlook
Key Companies Profile & Market Share Insights The increasing availability of biospecimens, the market participants are expanding their offerings to keep pace with the rising demand for bio-storage solutions. For instance, in February 2020, Hamilton Storage launched new sample storage tubes along with RackWare racks at SLAS 2020 International Conference and Exhibition. Some prominent players in the global biobanks market include:
Order a free sample PDF of the Biobanks Market Intelligence Study, published by Grand View Research. Mycoplasma Testing Industry Overview
The global mycoplasma testing market size is expected to reach a value of USD 1.87 billion by 2027, expanding at a CAGR of 14.9%, according to a new report by Grand View Research, Inc. The demand for mycoplasma testing products is anticipated to rise in near future with growing R&D investments in the field of life sciences. Huge opportunities in the life sciences segment are spurring market growth. Rising investment in biotechnology and pharmaceutical industries with rising healthcare spending is expected to further fuel the growth. Government initiatives in the form of awareness campaigns for chronic diseases, such as cancer are also encouraging research-based activities. The National Research Council’s Industrial Research and Assistance Program (NRC-IRAP) provides technological support to small and medium scale life science companies in Canada involved in product development and innovation. According to Saudi Arabia’s 2030 Vision, its government is promoting the growth of pharmaceutical industries due to the fact that only 30% of its medication requirements are produced locally. Such factors are expected to drive market growth. Mycoplasma Testing Market Segmentation Grand View Research has segmented the global mycoplasma testing market on the basis of product, technology, application, end-use, and region: Based on the Product Insights, the market is segmented into Instruments, Kits & Reagents, Services.
Based on the Application Insights, the market is segmented into Cell Line Testing, Virus Testing, End of Production Cells Testing, Others.
Based on the Technology Insights, the market is segmented into PCR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques, Enzymatic Methods.
Based on the End-use Insights, the market is segmented into Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others.
Mycoplasma Testing Regional Outlook
Key Companies Profile & Market Share Insights The major strategies adopted by these companies include mergers and acquisitions, new product development, and geographical expansions. For instance, in 2019, Lonza expanded its mycoplasma detection portfolio by launching the new luminometer Lucetta 2-a product used to accelerate and simplify the detection of mycoplasma in cell cultures. Some prominent players in the global mycoplasma testing market include:
Order a free sample PDF of the Mycoplasma Testing Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Preterm Birth And PROM Testing Industry Overview The global preterm birth and PROM testing market size is expected to reach USD 1.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.0% from 2021 to 2028. Key factors that can be attributed to market growth are rising number of preterm births in developed and emerging economies, improving access to advanced neonatal and maternal care facilities, and introduction of new POC diagnostic products over the forecast period. Preterm births are not specific to a particular geography and have been recognized as a worldwide concern. The risk of preterm births typically escalates with increasing average age of pregnant women. With growing awareness about preterm births and its consequence, the tendency of pregnant women to enroll for Premature Rupture of Membranes (PROM) testing during their pregnancy is anticipated to increase, for reassurance and monitoring of symptoms of preterm birth. Point-of-Care (POC) diagnostics have drastically altered the methodology of testing in various fields. With the help of advanced technology, devices are able to assess analyte in a given sample. Companies are focusing on R&D to increase specificity and sensitivity of devices, which lowers the error rate. Hence, emphasis is being given to reducing sample size required for other medical testing. Preterm Birth And PROM Testing Market Segmentation Grand View Research has segmented the global preterm birth and PROM testing market on the basis of test type and region: Based on the Type Insights, the market is segmented into Pelvic exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), Others.
Preterm Birth And PROM Testing Regional Outlook
Key Companies Profile & Market Share Insights The market is highly competitive with presence of many global and local players. The major companies are involved in adopting different growth strategies such as new product development, product differentiation strategies, and expansion of geographical reach in an attempt to capture large share of the market. Some prominent players in the global preterm birth and PROM testing market include
Order a free sample PDF of the Preterm Birth And PROM Testing Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: https://www.grandviewresearch.com Follow Us: LinkedIn | Twitter Cell Separation Industry Overview The global cell separation market size is expected to reach USD 25.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 18.8% from 2021 to 2028. Growing focus on biomolecule and cancer research, and rising incidence of chronic and infectious diseases, including the outbreak of COVID-19, are major factors contributing towards the growth of the market. Cell separation products are widely used by researchers and healthcare professionals for the development and production of novel therapies such as gene therapies and regenerative medicines. Continuous technological advancements and the introduction of more efficient products by key players have significantly supported the market growth. Cell Separation Market Segmentation Grand View Research has segmented the global cell separation market on the basis of product, cell type, technique, application, end use, and region: Based on the Product Insights, the market is segmented into consumables, instruments.
Based on the Cell Type Insights, the market is segmented into human, animal.
Based on the Technique Insights, the market is segmented into centrifugation, surface marker, filtration.
Based on the Application Insights, the market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, therapeutics.
Based on the End-use Insights, the market is segmented into research laboratories and institutes, hospitals and diagnostic laboratories, cell banks, biotechnology and biopharmaceutical companies.
Cell Separation Regional Outlook
Key Companies Profile & Market Share Insights Key players are engaged in organic and inorganic growth strategies such as product development, collaborations, partnerships, mergers, and acquisitions to garner high market share. Some prominent players in the global Cell Separation market include:
Order a free sample PDF of the Cell Separation Market Intelligence Study, published by Grand View Research. |
Archives
December 2023
Categories |